← Leaderboards
Robert R. Clarke
Georgetown University
$13,679,896
Attributed
$15,033,567
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$21,976,731 · 14
By mechanism
U54$12,021,608 · 3
R01$4,708,929 · 3
U01$2,707,343 · 1
P30$918,626 · 2
U09$620,000 · 1
G20$494,355 · 1
Top collaborators
- Yue Wang5 shared
Most similar at Georgetown University
Same institution · by research overlap
- Moshe Levi$17,675,566
- Alejandra Hurtado De Mendoza Casaus$3,088,220
- Seyedehfatemeh Razavipour$75,768
- Joyce Marie Slingerland$12,812,016
- Vanessa B Sheppard$7,900,849
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionMalignant Breast NeoplasmResponseComputer SimulationEndocrineProteinsHormone TherapyApoptosisAutophagocytosisGenesCellsAffectInnovationBreast Cancer CellResearch PersonnelProgramsComplementary DnaLeadTamoxifenNewly DiagnosedEstrogensMultidisciplinaryCancer PatientMammary Neoplasms
Grant awards (55)
Research Program - Breast Cancer$82,511
P30 · FY2020 · CA · contact PI
Research Program - Breast Cancer$82,511
P30 · FY2019 · CA · contact PI
Collaborative Research in Integrative Cancer Biology$521,796
U01 · FY2018 · CA · contact PI
Collaborative Research in Integrative Cancer Biology$458,386
U01 · FY2017 · CA · contact PI
Collaborative Research in Integrative Cancer Biology$568,354
U01 · FY2016 · CA · contact PI
Collaborative Research in Integrative Cancer Biology$564,382
U01 · FY2015 · CA · contact PI
Integration of ER-related signaling in breast cancer$1,289,047
U54 · FY2014 · CA · contact PI
Endocrine Responsiveness and Cellular Stress$805,497
U54 · FY2014 · CA · contact PI
Collaborative Research in Integrative Cancer Biology$594,425
U01 · FY2014 · CA · contact PI
Admin Core$104,567
U54 · FY2014 · CA · contact PI
Integration of ER-related signaling in breast cancer$1,296,700
U54 · FY2013 · CA · contact PI
Endocrine Responsiveness and Cellular Stress$981,668
U54 · FY2013 · CA · contact PI
Endocrine resistance in breast cancer$419,096
R01 · FY2013 · CA · contact PI
Admin Core$119,909
U54 · FY2013 · CA · contact PI
Integration of ER-related signaling in breast cancer$1,417,547
U54 · FY2012 · CA · contact PI
Endocrine Responsiveness and Cellular Stress$885,374
U54 · FY2012 · CA · contact PI
Endocrine resistance in breast cancer$308,958
R01 · FY2012 · CA · contact PI
Admin Core$107,802
U54 · FY2012 · CA · contact PI
Endocrine resistance in breast cancer$10,937
R01 · FY2012 · CA · contact PI
Integration of ER-related signaling in breast cancer$1,440,271
U54 · FY2011 · CA · contact PI
Endocrine Responsiveness and Cellular Stress$894,412
U54 · FY2011 · CA · contact PI
Endocrine resistance in breast cancer$308,958
R01 · FY2011 · CA · contact PI
Admin Core$107,802
U54 · FY2011 · CA · contact PI
Endocrine resistance in breast cancer$59,334
R01 · FY2011 · CA · contact PI
Integration of ER-related signaling in breast cancer$1,499,599
U54 · FY2010 · CA · contact PI
Endocrine Responsiveness and Cellular Stress$960,277
U54 · FY2010 · CA · contact PI
SPF RODENT HOUSING RENOVATION$494,355
G20 · FY2010 · RR · contact PI
Endocrine resistance in breast cancer$318,513
R01 · FY2010 · CA · contact PI
Admin Core$111,136
U54 · FY2010 · CA · contact PI
Endocrine resistance in breast cancer$318,513
R01 · FY2009 · CA · contact PI
Molecular Analysis of Human Breast Cancer$526,652
R01 · FY2007 · CA · contact PI
Molecular Analysis of Human Breast Cancer$482,179
R01 · FY2006 · CA · contact PI
Molecular Analysis of Human Breast Cancer$479,837
R01 · FY2005 · CA
CHAIRMAN'S GRANT$200,000
U09 · FY2005 · AT
CHAIRMAN'S GRANT$150,000
U09 · FY2005 · AT
Molecular Analysis of Human Breast Cancer$466,280
R01 · FY2004 · CA
CHAIRMAN'S GRANT$270,000
U09 · FY2004 · AT
Molecular Analysis of Human Breast Cancer$564,550
R01 · FY2003 · CA
RETINOID REGULATED GENES$135,290
P50 · FY2002 · CA
CORE--ANIMAL FACILITY$0
P30 · FY2002 · CA
CORE--ANIMAL FACILITY$0
P30 · FY2002 · CA
ESTROGEN INDUCED PROGRESSION IN BREAST CANCER$225,482
R01 · FY2001 · CA
CORE--ANIMAL FACILITY$150,220
P30 · FY2001 · CA
RETINOID REGULATED GENES$135,290
P50 · FY2001 · CA
DEVELOPMENT OF MULTI-RECEPTOR LC STATIONARY PHASES$100,000
R41 · FY2001 · GM
CORE--ANIMAL FACILITY$0
P30 · FY2001 · CA
CORE--ANIMAL FACILITY$0
P30 · FY2001 · CA
CORE--ANIMAL FACILITY$0
P30 · FY2001 · CA
GENES ACTIVATED OR INACTIVATED BY DIETARY COMPONENTS$0
P20 · FY2001 · CA
ESTROGEN INDUCED PROGRESSION IN BREAST CANCER$219,640
R01 · FY2000 · CA
CORE--ANIMAL FACILITY$152,724
P30 · FY2000 · CA
CORE--ANIMAL FACILITY$150,220
P30 · FY2000 · CA
CORE--ANIMAL FACILITY$150,220
P30 · FY2000 · CA
CORE--ANIMAL FACILITY$150,220
P30 · FY2000 · CA
RETINOID REGULATED GENES$135,290
P50 · FY2000 · CA